Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations (Q36111438)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

hereditary breast ovarian cancer

1 reference

based on heuristic

inferred from title

Steven A. Narod

4

object named as

Steven A Narod

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

author name string

Murray Joseph Casey

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Carrie Synder

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Chhanda Bewtra

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Patrice Watson

5

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Henry T Lynch

6

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

457-467

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Current status of prophylactic surgery for hereditary breast and gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Papillary peritoneal tumors in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Serous surface carcinoma of the peritoneum: A clinicopathologic study of 22 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

BRCA1 germline mutations in women with uterine serous papillary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Cancer Incidence in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Pathologic findings in prophylactic oophorectomy specimens in high-risk women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Ovarian surface epithelium: biology, endocrinology, and pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Serous borderline tumors of the ovary with noninvasive peritoneal implants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Epithelial ovarian tumors of low malignant potential: the role of microinvasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

A critical analysis of laparoscopic assisted vaginal hysterectomies compared with vaginal hysterectomies unassisted by laparoscopy and transabdominal hysterectomies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Chemoprevention of breast cancer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

The effects of tamoxifen on the female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Endometrial pathologies associated with postmenopausal tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Hormone replacement therapy in breast cancer survivors: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Hormone replacement therapy and risk of breast cancer: the role of progestins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Hormone replacement therapy and risk of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

Multiple focal extraovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.01.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2005.01.039

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36111438&oldid=1618129907"